Mixed epithelial and mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report.
Mixed epithelial and mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report.
复制标题
乳腺混合性上皮和间质化生癌（癌肉瘤）：病例报告。
DOI：
10.1186/2047-783x-19-14
复制
发表时间：
2014-03-13
影响因子：
4.2
通讯作者：
Zheng X
中科院分区：
文献类型：
--
作者：
Kang Y;Kang S;Li Q;Zheng X
化生性乳腺癌是一种罕见的恶性肿瘤，其特征是两种或多种细胞类型共存，通常是上皮和间质成分的混合物。本文报告一位46岁的女性乳癌肉瘤病例，包括乳房摄影、超音波、大体检查及病理结果。病人接受左乳改良根治术及后续六个疗程的辅助化疗及内分泌治疗后，目前情况良好，无复发及转移。浸润性导管癌（IDC）的常规治疗似乎效果较差。MBC患者将是创新或靶向治疗方案的合适候选人。
Metaplastic breast carcinoma (MBC) is an uncommon malignancy characterized by the co-existence of two or more cellular types, commonly a mixture of epithelial and mesenchymal components. A case of a female patient aged 46 years with MBC (carcinosarcoma) is presented, including mammographic, ultrasonic, gross examination, and pathological findings. After undergoing modified radical mastectomy of the left breast and subsequent six courses of adjuvant chemotherapy and endocrine therapy, the patient is now doing well with no recurrence and metastasis. Conventional treatments for invasive ductal carcinoma (IDC) may appear to be less effective. Patients with MBC would be appropriate candidates for innovative or targeted therapy regimens.